{
  "note_id": "gold_htn_followup_009",
  "scenario": "htn_followup",
  "persona": "gold",
  "note_text": "**Clinical Note**\n\n**Patient Name:** Sarah Johnson  \n**Age:** 39 years  \n**Gender:** Female  \n**Occupation:** Project Manager  \n\n**Chief Complaint:**  \n\"Blood pressure check\"\n\n**History of Present Illness:**  \nSarah Johnson is a 39-year-old female with a history of essential hypertension, returning for a follow-up visit. It has been 4 months since her last appointment. She was initiated on Lisinopril 10mg daily at that time. The patient reports taking her medication daily without any missed doses or side effects. Home blood pressure monitoring over the past 2 weeks shows an average of 138/86 mmHg. Her current blood pressure control is not at the target goal of <130/80 mmHg. She engages in physical activity by walking 3 times per week for 30 minutes and is attempting to reduce her sodium intake. Alcohol intake is limited to 2-3 beers over the weekend. She reports having regular menstrual periods, with her last menstrual period occurring 2 weeks ago, confirming she is not pregnant.  \n\n**Review of Systems:**  \n- Constitutional: No weight change, no fatigue  \n- Cardiovascular: No chest pain, no palpitations  \n- Respiratory: No shortness of breath, no cough  \n- Neurological: No headaches, no dizziness  \n- Gastrointestinal: No nausea, no abdominal pain  \n- Genitourinary: Regular menstrual periods, not pregnant  \n- Musculoskeletal: No joint pain  \n- Dermatological: No rashes  \n\n**Past Medical History:**  \n- Hypertension  \n\n**Medications:**  \n- Lisinopril 10mg daily  \n\n**Allergies:**  \n- No known drug allergies  \n\n**Social History:**  \n- Occupation: Project Manager  \n- Exercise: Walks 3x/week for 30 min  \n- Diet: Reducing sodium intake  \n- Alcohol: 2-3 beers on weekends  \n- Tobacco: Non-smoker  \n- Contraception: Not applicable (regular menstrual cycles, not postmenopausal)  \n\n**Physical Examination:**  \n- Vital Signs: BP 142/88 mmHg right arm, 140/86 mmHg left arm (seated, repeated after 5 min rest), HR 74, Weight 192 lbs, BMI 28.3  \n- General: Alert, well-appearing, overweight  \n- Cardiovascular: Regular rate and rhythm, no murmurs, peripheral pulses 2+ bilaterally  \n- Respiratory: Clear lung fields bilaterally  \n- Extremities: No edema  \n- Fundoscopic: No papilledema  \n\n**Assessment and Plan:**  \n1. **Essential hypertension, uncontrolled (ICD-10: I10):**  \n   - Increase Lisinopril to 20mg daily.  \n   - Continue home blood pressure monitoring, record twice daily for 1 week before next visit.  \n   - Return in 6-8 weeks to assess BP response to medication increase.  \n   - Patient education on target BP <130/80 and importance of medication adherence.  \n\n2. **Overweight (ICD-10: E66.3):**  \n   - Lifestyle counseling: Adopt DASH diet, reduce sodium intake to <2000mg/day, limit alcohol to <2 drinks/day.  \n   - Increase exercise to 5x/week.  \n   - Weight loss goal: Lose 10 lbs over 3 months.  \n\n3. **Laboratory Monitoring:**  \n   - Recheck BMP and lipid panel in 6 months.  \n   - Consider statin if LDL remains elevated at next visit.  \n\n4. **Contraception Counseling:**  \n   - Discussed the importance of reliable contraception due to ACE inhibitors being contraindicated in pregnancy.  \n\n**Time Spent:**  \n20 minutes with extensive counseling on lifestyle modifications.\n\n**Billing Level:**  \n99214 (Established patient, moderate complexity)\n\n**Medical Decision Making:**  \nThe decision to increase the Lisinopril dose was made based on persistently elevated BP despite good adherence. Cardiovascular risk assessment indicates a 10-year ASCVD risk of approximately 12%, necessitating aggressive BP control. Discussed lifestyle modifications at length. Considered the addition of a second antihypertensive agent but opted to first increase the dose of the current medication.",
  "demographics": {
    "age": 39,
    "gender": "F",
    "occupation": "project manager",
    "name": "Sarah Johnson"
  },
  "generated_at": "2026-02-14T01:54:34.732224",
  "ground_truth_scores": {
    "completeness": 92,
    "accuracy": 95,
    "compliance": 90,
    "risk": 85,
    "clarity": 93
  }
}